Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor

Journal of Biological Chemistry

Volumn 287, Issue 45, 2012, Pages 38244-38253

  Lu, Chafen ^a   Mi, Li Zhi ^a   Schürpf, Thomas ^a   Walz, Thomas ^b   Springer, Timothy A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECTODOMAIN; EPIDERMAL GROWTH FACTOR RECEPTORS; KINASE DOMAINS; KINASE INHIBITORS; SMALL MOLECULES; TRANS-MEMBRANE DOMAINS;

ACTIVATION ANALYSIS; CONFORMATIONS; DIMERIZATION;

ENZYMES;

DISULFIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOTRANSFERASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CROSS LINKING; DIMERIZATION; DISULFIDE BOND; ENERGY TRANSFER; ENZYME ACTIVATION; ENZYME CONFORMATION; EXON; GEL FILTRATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE; CROSS-LINKING REAGENTS; DISULFIDES; EPIDERMAL GROWTH FACTOR; HUMANS; MICROSCOPY, ELECTRON; MUTATION; PHOSPHOTRANSFERASES; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84868323253     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.414391     Document Type: Article

References (32)

1. Hynes, N. E., and Lane, H. A. (2005) ERBB receptors and cancer. The complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354 (Pubitemid 40637826)
2. Arteaga, C. L. (2003) ErbB-targeted therapeutic approaches in human cancer. Exp. Cell Res. 284, 122-130 (Pubitemid 36331971)
3. Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H. S., Leahy, D. J., and Lemmon, M. A. (2003) EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 11, 507-517 (Pubitemid 36297057)
4. Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J. H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., and Yokoyama, S. (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775-787 (Pubitemid 35291060)
5. Garrett, T. P., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H. J., Walker, F., Frenkel, M. J., Hoyne, P. A., Jorissen, R. N., Nice, E. C., Burgess, A. W., and Ward, C. W. (2002) Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110, 763-773 (Pubitemid 35283965)
6. Cho, H. S., and Leahy, D. J. (2002) Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297, 1330-1333 (Pubitemid 34913167)
7. Mi, L. Z., Lu, C., Li, Z., Nishida, N., Walz, T., and Springer, T. A. (2011) Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat. Struct. Mol. Biol. 18, 984-989
8. Jura, N., Endres, N. F., Engel, K., Deindl, S., Das, R., Lamers, M. H., Wemmer, D. E., Zhang, X., and Kuriyan, J. (2009) Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137, 1293-1307
9. Lu, C., Mi, L. Z., Grey, M. J., Zhu, J., Graef, E., Yokoyama, S., and Springer, T. A. (2010) Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol. Cell Biol. 30, 5432-5443
10. Zhang, X., Gureasko, J., Shen, K., Cole, P. A., and Kuriyan, J. (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-1149 (Pubitemid 43866200)
11. Dawson, J. P., Berger, M. B., Lin, C. C., Schlessinger, J., Lemmon, M. A., and Ferguson, K. M. (2005) Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol. Cell Biol. 25, 7734-7742 (Pubitemid 41170134)
12. Red Brewer, M., Choi, S. H., Alvarado, D., Moravcevic, K., Pozzi, A., Lemmon, M. A., and Carpenter, G. (2009) The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 34, 641-651
13. Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R., and Mekada, E. (2002) Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 13, 2547-2557 (Pubitemid 34831354)
14. Chantry, A. (1995) The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J. Biol. Chem. 270, 3068-3073
15. Arteaga, C. L., Ramsey, T. T., Shawver, L. K., and Guyer, C. A. (1997) Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. J. Biol. Chem. 272, 23247-23254 (Pubitemid 27392460)
16. Lichtner, R. B., Menrad, A., Sommer, A., Klar, U., and Schneider, M. R. (2001) Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. Cancer Res. 61, 5790-5795 (Pubitemid 32769096)
17. Gan, H. K., Walker, F., Burgess, A. W., Rigopoulos, A., Scott, A. M., and Johns, T. G. (2007) The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. J. Biol. Chem. 282, 2840-2850 (Pubitemid 47084315)
18. Stamos, J., Sliwkowski, M. X., and Eigenbrot, C. (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277, 46265-46272 (Pubitemid 35417619)
19. Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., Alligood, K. J., Rusnak, D. W., Gilmer, T. M., and Shewchuk, L. (2004)Aunique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib). Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res. 64, 6652-6659 (Pubitemid 39297926)
20. Yun, C. H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., and Eck, M. J. (2007) Structures of lung cancer-derived EGFR mutants and inhibitor complexes. Mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 11, 217-227 (Pubitemid 46349842)
21. Blair, J. A., Rauh, D., Kung, C., Yun, C. H., Fan, Q. W., Rode, H., Zhang, C., Eck, M. J., Weiss, W. A., and Shokat, K. M. (2007) Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat. Chem. Biol. 3, 229-238 (Pubitemid 46440537)
22. Ludtke, S. J., Baldwin, P. R., and Chiu, W. (1999) EMAN. Semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128, 82-97 (Pubitemid 30013436)
23. Frank, J., Radermacher, M., Penczek, P., Zhu, J., Li, Y., Ladjadj, M., and Leith, A. (1996) SPIDER and WEB. Processing and visualization of images in 3D electron microscopy and related fields. J. Struct. Biol. 116, 190-199 (Pubitemid 26093143)
24. Mi, L. Z., Grey, M. J., Nishida, N., Walz, T., Lu, C., and Springer, T. A. (2008) Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Biochemistry 47, 10314-10323
25. Li, S., Schmitz, K. R., Jeffrey, P. D., Wiltzius, J. J., Kussie, P., and Ferguson, K. M. (2005) Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7, 301-311 (Pubitemid 40544648)
26. Chung, I., Akita, R., Vandlen, R., Toomre, D., Schlessinger, J., and Mellman, I. (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464, 783-787
27. Macdonald, J. L., and Pike, L. J. (2008) Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. U.S.A. 105, 112-117
28. Yarden, Y., and Schlessinger, J. (1987) Self-phosphorylation of epidermal growth factor receptor. Evidence for a model of intermolecular allosteric activation. Biochemistry 26, 1434-1442 (Pubitemid 17045874)
29. Eck, M. J., and Yun, C. H. (2010) Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer. Biochim. Biophys. Acta 1804, 559-566
30. Yun, C. H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K. K., Meyerson, M., and Eck, M. J. (2008) The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc. Natl. Acad. Sci. U.S.A. 105, 2070-2075 (Pubitemid 351439466)
31. Alvarado, D., Klein, D. E., and Lemmon, M. A. (2009) ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature 461, 287-291
32. Garrett, T. P., Burgess, A. W., Gan, H. K., Luwor, R. B., Cartwright, G., Walker, F., Orchard, S. G., Clayton, A. H., Nice, E. C., Rothacker, J., Catimel, B., Cavenee, W. K., Old, L. J., Stockert, E., Ritter, G., Adams, T. E., Hoyne, P. A., Wittrup, D., Chao, G., Cochran, J. R., Luo, C., Lou, M., Huyton, T., Xu, Y., Fairlie, W. D., Yao, S., Scott, A. M., and Johns, T. G. (2009) Antibodies specifically targeting a locally misfolded region of tumor associated EGFR. Proc. Natl. Acad. Sci. U.S.A. 106, 5082-5087